Establishment and characterization of an angiosarcoma-derived cell line, AS-M

Endothelium: Journal of Endothelial Cell Research

Volumn 10, Issue 6, 2003, Pages 319-328

  Krump Konvalinkova, Vera ^a   Bittinger, Fernando ^a   Olert, Jürgen ^a   Bräuninger, Wolfgang ^a   Brunner, Joachim ^a   Kirkpatrick, C James ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angiosarcoma; AS M; Endothelial cell line

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; ACETYL LOW DENSITY LIPOPROTEIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOGLIN; GENE PRODUCT; LIPOPOLYSACCHARIDE; PROTEIN P53; PROTEIN TYROSINE KINASE; TIE 1 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

AGED; ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL CLONE; CELL GROWTH; CELL ISOLATION; CELL NUCLEUS; CELL POPULATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CONTROLLED STUDY; DIPLOIDY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO PROPAGATION; IN VITRO STUDY; INOCULATION; KARYOTYPE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TUMOR GROWTH; ULEX EUROPAEUS;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS; ULEX; ULEX EUROPAEUS;

EID: 1142287595     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320390272316     Document Type: Article

References (40)

1. Abrahamson T.G., Stone M.S., and Piette W.W. (2001) Cutaneous angiosarcoma. Advances in Dermatology, 17, 279-299.
2. Albelda S.M., Oliver P.D., Romer L.H., and Buck C.A. (1990) EndoCAM: A novel endothelial cell-cell adhesion molecule. Journal of Cell Biology, 110, 1227-1237.
3. Amo T., Masuzawa M., Hamada Y., and Katsuoka K. (2001) Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Archives of Dermatological. Research, 293, 296-301.
4. Bocklage T., Leslie K., Yousem S., and Colby T. (2001) Extracutaneous angiosarcomas metastatic to the lungs: Clinical and pathologic features of twenty-one cases. Modern Pathology, 14, 1216-1225.
5. Brown L.F., Dezube B.J., Tognazzi K., Dvorak H.F., and Yancopoulos G.D. (2000) Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. American Journal of Pathology, 156, 2179-2183.
6. Brown L.F., Tognazzi K., Dvorak H.F. and Harrist T.J. (1996) Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. American Journal of Pathology, 148, 1065-1074.
7. Burgdorf W.H., Mukai K., and Rosai J. (1981) Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature. American Journal of Clinical Pathology, 75, 167-171.
8. Carstens P.H. (1981) The Weibel-Palade body in the diagnosis of endothelial tumors. Ultrastructural Pathology, 2, 315-325.
9. DeYong B.R., Swanson P.E., Argenyi Z.B., Ritter J.H., Fitzgibbon J.F., Stahl D.J., Hoover W., and Wick M.R. (1995) CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: Report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. Journal of Cutaneous Pathology, 22, 215-222.
10. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Jr., Butel J.S., and Bradley A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221.
11. Elgjo R.F., Henriksen T., and Evensen S.A. (1975) Ultrastructural identification of umbilical cord vein endothelium in situ and in culture. Cell and Tissue Research, 162, 49-59.
12. Gordon P.B., Sussman I.I., and Hatcher V.B. (1983) Long-term culture of human endothelial cells. In Vitro Cellular and Developmental Biology, 19, 661-671.
13. Gougos A., and Letarte M. (1988) Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line. Journal of Immunology, 141, 1934-1940.
14. Greenblatt M.S., Bennett W.P., Hollstein M., and Harris C.C. (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Research, 54, 4855-4878.
15. Hashimoto M., Ohsawa M., Ohnishi A., Naka N., Hirota S., Kitamura Y., and Aosaza K. (1995) Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Laboratory Investigation, 73, 859-863.
16. Hohenwarter O., Schmatz C., and Katinger H. (1992) Stability of von Willebrand factor secretion in different human endothelial hybrid cell lines. Cytotechnology, 8, 31-37.
17. Holden C.A., Spaull J., Das A.K., McKee P.H., and Jones E.W. (1987) The histogenesis of angiosarcoma of the face and scalp: An immunohistochemical and ultrastructural study. Histopathology, 11, 37-51.
18. Holthofer H., Virtanen I., Kariniemi A.L., Hormia M., Linder E., and Miettinen A. (1982) Ulex europeaus I lectin as a marker for vascular endothelium in human tissues. Laboratory Investigation, 47, 60-66.
19. Hoover M.L., Vetvicka V., Hoffpauir J.M., and Tamburro C.H. (1993) Human endothelial cell line from an angiosarcoma. In Vitro Cellular and Developmental Biology, 29A, 199-202.
20. Kindblom L.G., Stenman G., and Angervall L. (1991) Morphological and cytogenetical studies of angiosarcoma in Stewart-Trewes syndrome. Virchows Archive A: Pathological Anatomy and Histopathology, 419, 439-445.
21. Krause D.S., Fackler M.J., Civin C.I., and May W.S. (1996) CD34: Structure, biology, and clinical utility. Blood, 87, 1-13.
22. Masuzawa M., Fujimura T., Hamada Y., Fujita Y., Hara H., Nishiyama S., Katsuoka K., Tamauchi H., and Sakurai Y. (1999) Establishment of a human hemangiosarcoma cell line (ISO-HAS). International Journal of Cancer, 81, 305-308.
23. Meis-Kindblom J.M., and Kindblom L.G. (1998) Angiosarcoma of soft tissue: A study of 80 cases. American Journal of Surgical Pathology, 22, 683-697.
24. Naka N., Tomita Y., Nakanishi H., Araki N., Hongyo T., Ochi T., and Aosaza K. (1997) Mutations of p53 tumor suppressor gene in angiosarcoma. International Journal of Cancer, 71, 952-955.
25. Ohsawa M., Nakan N., Tomita Y., Kawamori D., Kanno H., and Aozasa K. (1995) Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer, 75, 2867-2874.
26. Orchard G.E., Zelger B., Jones E.W., and Jones R.R. (1996) An immunocytochemical assessment of 19 cases of cutaneous angiosarcoma. Histopathology, 28 235-240.
27. Porter P.L., Gown A.M., Kramp S.G., and Coltrera M.D. (1992) Widespread p53 overexpression in human malignant tumors. Immunohistochemical study using methacarn-fixed, embedded tissue. American Journal of Pathology, 140, 145-153.
28. Schuborg C., Mertens F., Rydholm A., Bronsjo O., Dictor M., Mitelman F., and Mandahl N. (1998) Cytogenetic analysis of four angioarcomas from deep and superficial soft tissue. Cancer Genetics and Cytogenetics, 100, 52-56.
29. Seabright M. (1971) A rapid banding technique for human chromosomes. Lancet, 2, 971-272.
30. Soini Y., Welsch J.A., Ishak K.G., and Bennett W.P. (1995) p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. Carcinogenesis, 16, 2879-2881.
31. Sutherland D.R., Marsh J.C., Davidson J., Baker M.A., Keating A., and Mellors A. (1992) Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Experimental Hematology, 20, 590-599.
32. Traweek S.T., Kandalaft P.L., Mehta P., and Battifora H. (1991) The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. American Journal of Clinical Pathology, 96, 25-31.
33. Unger R.E., Krump-Konvalinkova V., Peters K., and Kirkpatrick C.J. (2002) In vitro expression of endothelial phenotype: Comparative study of primary isolated cells and cell lines, including the novel cell line, HPMEC-ST1.6R. Microvascular Research, 64, 384-397.
34. Voyta J.C., Via D.P., Butterfield C.E., and Zetter B.R. (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipopolyprotein. Journal of Cell Biology, 99, 2034-2040.
35. Wagner D.D., Olmsted J.B., and Marder V.J. (1982) Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. Journal of Cell Biology, 95, 355-360.
36. Wong K.F., So C.C., Wong N., Siu L.L.,Kwong Y.L., and Chan J.K. (2001) Sinonasal angiosarcoma with marrow involvement at presentation mimicking malignant lymphoma: Cytogenetic analysis using multiple techniques. Cancer Genetics and Cytogenetics, 129, 64-68.
37. Zenklusen J.C., Conti C.J., and Green E.D. (2001) Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nature Genetics, 27, 392-398.
38. Zhang L., Aviv H., Gardner J.P., Okuda K., Patel S., Kimura M., Bardeguez A., and Aviv A. (2000) Loss of chromosome 13 in cultured human vascular endothelial cells. Experimental Cell Research, 260, 357-364.
39. Zietz C., Rossle M., Haas C., Sendelhofert A., Hirschmann A., Sturzl M., and Lohrs U. (1998) MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. American Journal of Pathology, 153, 425-433.
40. Zu Y., Perle M.A., Yan Z., Liu J., Kumar A., and Waisman J. (2001) Chromosomal abnormalities and p53 mutation in a cardiac angiosarcoma. Applied Immunohistochemistry & Molecular Morphology, 9, 24-28.